Alzamend Neuro, Inc. SEC filings ALZN
Alzamend Neuro, Inc. has 397 filings in SEC EDGAR's recent list, going back to Jun 22, 2016. Its latest annual report, Form 10-K, was filed on Jul 22, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 10, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (regulation fd disclosure). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| RW | Filing | Oct 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2026 | Sep 29, 2026 |
| 10-Q | Quarterly report | Sep 10, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Aug 31, 2026 | Aug 26, 2026 |
| 4/A | Primary document | Aug 31, 2026 | Apr 14, 2026 |
| 4/A | Primary document | Aug 31, 2026 | Apr 14, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 28, 2026 | Oct 19, 2026 |
| S-1 | Registration statement | Aug 21, 2026 | — |
| 4/A | Primary document | Aug 20, 2026 | Jul 31, 2026 |
| 3/A | Primary document | Aug 20, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Jul 31, 2026 |
| 3 | Initial insider ownership | Aug 4, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Jul 31, 2026 |
| 5 | Annual insider ownership | Aug 4, 2026 | Apr 30, 2026 |
| 5 | Annual insider ownership | Aug 4, 2026 | Apr 30, 2026 |
| 5 | Annual insider ownership | Aug 4, 2026 | Apr 30, 2026 |
| 5 | Annual insider ownership | Aug 4, 2026 | Apr 30, 2026 |
| 5 | Annual insider ownership | Aug 4, 2026 | Apr 30, 2026 |
| 5 | Annual insider ownership | Aug 4, 2026 | Apr 30, 2026 |
| 5 | Annual insider ownership | Aug 4, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale, Bylaw or fiscal year change
|
Aug 3, 2026 | Aug 3, 2026 |
| 10-K | Annual report | Jul 22, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 21, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 17, 2026 | Apr 17, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 20, 2026 | Mar 20, 2026 |
| 10-Q | Quarterly report | Mar 11, 2026 | Jan 31, 2026 |
| 424B5 | Prospectus supplement | Mar 6, 2026 | — |
| 8-K |
Current report
Material agreement
|
Mar 6, 2026 | Mar 6, 2026 |
| DEFA14A | Additional proxy material | Feb 26, 2026 | — |
| DEF 14A | Proxy statement | Feb 26, 2026 | Apr 17, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 9, 2026 | Apr 17, 2026 |
| 4 | Insider transaction | Dec 30, 2025 | Dec 23, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 19, 2025 |
| 10-Q | Quarterly report | Dec 9, 2025 | Oct 31, 2025 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 14, 2025 | Oct 14, 2025 |
| 4 | Insider transaction | Oct 10, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Oct 9, 2025 | Oct 9, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 3, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 7, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 3, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 30, 2025 | — |
| 4 | Insider transaction | Sep 30, 2025 | Sep 26, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 25, 2025 | — |
| 4 | Insider transaction | Sep 25, 2025 | Sep 23, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Sep 25, 2025 | Sep 25, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 23, 2025 | — |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 19, 2025 | Sep 17, 2025 |
| 10-Q | Quarterly report | Sep 10, 2025 | Jul 31, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 1, 2025 | — |
| 8-K |
Current report
Unregistered share sale
|
Aug 1, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 1, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Jul 29, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Jul 25, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2025 | Jul 23, 2025 |
| 10-K | Annual report | Jul 22, 2025 | Apr 30, 2025 |
| 144/A | Filing | Jul 11, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 9, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 12, 2025 |
| 144 | Notice of proposed sale | May 9, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 25, 2025 | Apr 25, 2025 |
| 424B3 | Prospectus | Apr 9, 2025 | — |
| EFFECT | Filing | Apr 8, 2025 | — |
| CORRESP | Letter to the SEC | Apr 4, 2025 | — |
| S-1/A | Amended registration statement | Mar 27, 2025 | — |
| 4 | Insider transaction | Mar 27, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 21, 2025 |
| UPLOAD | Letter from the SEC | Mar 21, 2025 | — |
| 4 | Insider transaction | Mar 20, 2025 | Mar 20, 2025 |
| DEFA14A | Additional proxy material | Mar 19, 2025 | — |
| 4 | Insider transaction | Mar 19, 2025 | Mar 18, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 18, 2025 |
| DEFA14A | Additional proxy material | Mar 17, 2025 | — |
| 4 | Insider transaction | Mar 14, 2025 | Mar 12, 2025 |
| DEF 14A | Proxy statement | Mar 13, 2025 | Apr 25, 2025 |
| S-3 | Shelf registration | Mar 13, 2025 | — |
| 10-Q | Quarterly report | Mar 10, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 3, 2025 | Mar 3, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 28, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 28, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations
|
Dec 12, 2024 | Dec 12, 2024 |
| 10-Q | Quarterly report | Dec 11, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2024 | Oct 15, 2024 |
| 424B5 | Prospectus supplement | Oct 3, 2024 | — |
| 8-K |
Current report
Material agreement
|
Oct 3, 2024 | Oct 3, 2024 |
| 10-Q | Quarterly report | Sep 11, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 1, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2024 | Jul 31, 2024 |
| 10-K | Annual report | Jul 30, 2024 | Apr 30, 2024 |
| NT 10-K | Filing | Jul 30, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 12, 2024 | Jul 12, 2024 |
| 424B3 | Prospectus | Jul 10, 2024 | — |
| EFFECT | Filing | Jul 9, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 8, 2024 | Jul 8, 2024 |
| CORRESP | Letter to the SEC | Jul 8, 2024 | — |
| S-1/A | Amended registration statement | Jul 3, 2024 | — |
| CORRESP | Letter to the SEC | Jul 3, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2024 | — |
| S-1/A | Amended registration statement | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2024 | — |
| DEFA14A | Additional proxy material | Jun 11, 2024 | — |
| S-1 | Registration statement | Jun 3, 2024 | — |
| DEF 14A | Proxy statement | May 31, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 22, 2024 | May 22, 2024 |
| 5 | Annual insider ownership | May 16, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2024 | May 15, 2024 |
| 8-K | Current report | May 13, 2024 | May 13, 2024 |
| PRE 14A | Preliminary proxy statement | May 10, 2024 | May 10, 2024 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
May 10, 2024 | May 9, 2024 |
| 424B5 | Prospectus supplement | May 10, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Auditor change
|
May 9, 2024 | May 9, 2024 |
| 424B5 | Prospectus supplement | May 7, 2024 | — |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| DEFA14A | Additional proxy material | May 1, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 1, 2024 | May 1, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 30, 2024 | Apr 30, 2024 |
| 4 | Insider transaction | Apr 23, 2024 | Apr 19, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 1, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale
|
Mar 29, 2024 | Mar 29, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 10-Q | Quarterly report | Mar 25, 2024 | Jan 31, 2024 |
| DEF 14A | Proxy statement | Mar 25, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Mar 22, 2024 | Mar 22, 2024 |
| NT 10-Q | Filing | Mar 18, 2024 | Jan 31, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 13, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 7, 2024 | Mar 7, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 2, 2024 | — |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale, Bylaw or fiscal year change
|
Feb 2, 2024 | Feb 2, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 25, 2024 | — |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 9, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2024 | Jan 5, 2024 |
| 4 | Insider transaction | Dec 27, 2023 | Dec 22, 2023 |
| 10-Q | Quarterly report | Dec 15, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 30, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Listing notice, Shareholder vote results
|
Sep 29, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2023 | Sep 22, 2023 |
| 10-Q | Quarterly report | Sep 13, 2023 | Jul 31, 2023 |
| 424B5 | Prospectus supplement | Sep 8, 2023 | — |
| 8-K |
Current report
Material agreement
|
Sep 8, 2023 | Sep 8, 2023 |
| DEFA14A | Additional proxy material | Sep 1, 2023 | — |
| DEF 14A | Proxy statement | Aug 24, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Other events
|
Aug 16, 2023 | Aug 16, 2023 |
| EFFECT | Filing | Aug 10, 2023 | — |
| PRE 14A | Preliminary proxy statement | Aug 10, 2023 | Sep 20, 2023 |
| CORRESP | Letter to the SEC | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2023 | — |
| 8-K |
Current report
Listing notice
|
Aug 7, 2023 | Aug 7, 2023 |
| S-3 | Shelf registration | Aug 2, 2023 | — |
| 10-K | Annual report | Jul 27, 2023 | Apr 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2023 | Jun 22, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 24, 2023 |
| 4 | Insider transaction | May 2, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Apr 26, 2023 | Apr 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 25, 2023 | Apr 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 3, 2023 | Apr 3, 2023 |
| DEF 14A | Proxy statement | Mar 31, 2023 | Apr 26, 2023 |
| 4 | Insider transaction | Mar 23, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 22, 2023 | Mar 22, 2023 |
| 4 | Insider transaction | Mar 20, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 10-Q | Quarterly report | Mar 15, 2023 | Jan 31, 2023 |
| 4 | Insider transaction | Feb 28, 2023 | Feb 24, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Listing notice
|
Feb 3, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 20, 2023 | Jan 20, 2023 |
| 4 | Insider transaction | Dec 29, 2022 | Dec 27, 2022 |
| 4 | Insider transaction | Dec 23, 2022 | Dec 21, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 10-Q | Quarterly report | Dec 12, 2022 | Oct 31, 2022 |
| 4 | Insider transaction | Nov 30, 2022 | Nov 30, 2022 |
| 4 | Insider transaction | Nov 30, 2022 | Nov 30, 2022 |
| 4 | Insider transaction | Nov 30, 2022 | Nov 30, 2022 |
| 4 | Insider transaction | Nov 30, 2022 | Nov 29, 2022 |
| 4 | Insider transaction | Nov 21, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2022 | Nov 16, 2022 |
| 4 | Insider transaction | Nov 15, 2022 | Nov 11, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 15, 2022 | — |
| 4 | Insider transaction | Nov 3, 2022 | Nov 2, 2022 |
| 4 | Insider transaction | Nov 1, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2022 | Oct 31, 2022 |
| 4 | Insider transaction | Oct 14, 2022 | Oct 12, 2022 |
| 4 | Insider transaction | Oct 7, 2022 | Oct 6, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2022 | Oct 5, 2022 |
| 4 | Insider transaction | Sep 30, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2022 | Sep 29, 2022 |
| 4 | Insider transaction | Sep 26, 2022 | Sep 23, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALZN (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- DE
- Headquarters
- Atlanta, GA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1677077
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.